Mitchell Braxton D, McArdle Patrick F, Shen Haiqing, Rampersaud Evadnie, Pollin Toni I, Bielak Lawrence F, Jaquish Cashell, Douglas Julie A, Roy-Gagnon Marie-Hélène, Sack Paul, Naglieri Rosalie, Hines Scott, Horenstein Richard B, Chang Yen-Pei C, Post Wendy, Ryan Kathleen A, Brereton Nga Hong, Pakyz Ruth E, Sorkin John, Damcott Coleen M, O'Connell Jeffrey R, Mangano Charles, Corretti Mary, Vogel Robert, Herzog William, Weir Matthew R, Peyser Patricia A, Shuldiner Alan R
Division of Endocrinology, Department of Medicine, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Am Heart J. 2008 May;155(5):823-8. doi: 10.1016/j.ahj.2008.01.019. Epub 2008 Mar 5.
The etiology of cardiovascular disease (CVD) is multifactorial. Efforts to identify genes influencing CVD risk have met with limited success to date, likely because of the small effect sizes of common CVD risk alleles and the presence of gene by gene and gene by environment interactions.
The HAPI Heart Study was initiated in 2002 to measure the cardiovascular response to 4 short-term interventions affecting cardiovascular risk factors and to identify the genetic and environmental determinants of these responses. The measurements included blood pressure responses to the cold pressor stress test and to a high salt diet, triglyceride excursion in response to a high-fat challenge, and response in platelet aggregation to aspirin therapy.
The interventions were carried out in 868 relatively healthy Amish adults from large families. The heritabilities of selected response traits for each intervention ranged from 8% to 38%, suggesting that some of the variation associated with response to each intervention can be attributed to the additive effects of genes.
Identifying these response genes may identify new mechanisms influencing CVD and may lead to individualized preventive strategies and improved early detection of high-risk individuals.
心血管疾病(CVD)的病因是多因素的。迄今为止,识别影响心血管疾病风险的基因的努力取得的成功有限,这可能是因为常见心血管疾病风险等位基因的效应大小较小,以及存在基因与基因、基因与环境的相互作用。
HAPI心脏研究于2002年启动,旨在测量心血管系统对4种影响心血管危险因素的短期干预措施的反应,并确定这些反应的遗传和环境决定因素。测量内容包括对冷加压应激试验和高盐饮食的血压反应、对高脂肪挑战的甘油三酯波动以及对阿司匹林治疗的血小板聚集反应。
干预措施在来自大家庭的868名相对健康的阿米什成年人中进行。每种干预措施所选反应性状的遗传力范围为8%至38%,这表明与每种干预措施反应相关的一些变异可归因于基因的加性效应。
识别这些反应基因可能会发现影响心血管疾病的新机制,并可能导致个性化的预防策略以及改善高危个体的早期检测。